These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 4006401

  • 21. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N, Tsitsios T, Stambolidou M, Athanasiou G, Peiou M, Kokkinou V, Mavromatidis K.
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [Abstract] [Full Text] [Related]

  • 22. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Mar; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 23. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
    Pastor MC, Sierra C, Bonal J, Teixidó J.
    Am J Nephrol; 1993 Mar; 13(4):238-43. PubMed ID: 8267019
    [Abstract] [Full Text] [Related]

  • 24. [The influence of renal failure and renal replacement therapy on the activity of erythrocyte sodium-proton exchanger].
    Kwiatkowska E.
    Ann Acad Med Stetin; 2004 Mar; 50(1):25-33. PubMed ID: 16871741
    [Abstract] [Full Text] [Related]

  • 25. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 26. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 27. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A.
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [Abstract] [Full Text] [Related]

  • 28. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N.
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [Abstract] [Full Text] [Related]

  • 29. [Content of thiamin in plasma and erythrocytes in patients with end stage renal disease].
    Pietrzak I, Baczyk K, Młynarczyk M, Kaczmarek M.
    Przegl Lek; 1996 Oct; 53(5):423-6. PubMed ID: 8754406
    [Abstract] [Full Text] [Related]

  • 30. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T.
    Kidney Blood Press Res; 2004 Oct; 27(2):88-95. PubMed ID: 14739577
    [Abstract] [Full Text] [Related]

  • 31. Characterization of human erythrocyte choline transport in chronic renal failure.
    Riley SP, Talbot NJ, Ahmed MJ, Jouhal K, Hendry BM.
    Nephrol Dial Transplant; 1997 Sep; 12(9):1921-7. PubMed ID: 9306344
    [Abstract] [Full Text] [Related]

  • 32. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Sep; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 33. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [Abstract] [Full Text] [Related]

  • 34. Thyroid function and continuous ambulatory peritoneal dialysis.
    Semple CG, Beastall GH, Henderson IS, Thomson JA, Kennedy AC.
    Nephron; 1982 Jun; 32(3):249-52. PubMed ID: 7155243
    [Abstract] [Full Text] [Related]

  • 35. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 Jun; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 36. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS.
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [Abstract] [Full Text] [Related]

  • 37. Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis.
    Surendra NK, Abdul Manaf MR, Hooi LS, Bavanandan S, Mohamad Nor FS, Shah Firdaus Khan S, Ong LM, Abdul Gafor AH.
    BMC Nephrol; 2019 Apr 30; 20(1):151. PubMed ID: 31039745
    [Abstract] [Full Text] [Related]

  • 38. [Blood serum hepatocyte growth factor in children with chronic renal failure treated with CAPD and HD].
    Szprynger K, Szczepańska M, Morawiec-Knysak A, Dyduch A.
    Pol Merkur Lekarski; 2000 Apr 30; 8(46):270-1. PubMed ID: 10897645
    [Abstract] [Full Text] [Related]

  • 39. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
    Zwołińska D, Grzeszczak W, Szczepańska M, Kiliś-Pstrusińska K, Szprynger K.
    Pediatr Nephrol; 2006 May 30; 21(5):705-10. PubMed ID: 16518626
    [Abstract] [Full Text] [Related]

  • 40. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B, Supasyndh O, Phantana-Angkul P, Ruangkanchanasetr P, Nata N, Chaiprasert A, Kanjanakul I, Choovichian P.
    J Med Assoc Thai; 2011 Sep 30; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.